Phreesia Inc. to Acquire AccessOne for $160 Million, Expanding Payment Solutions Portfolio

Reuters
Sep 05
Phreesia Inc. to Acquire AccessOne for $160 Million, Expanding Payment Solutions Portfolio

Phreesia, Inc. (NYSE: PHR), a leader in patient activation, has announced a definitive agreement to acquire AccessOne Parent Holdings, Inc. for $160 million in cash. This acquisition will expand Phreesia's suite of payment solutions. The transaction is expected to close in the third quarter or early fourth quarter of Phreesia's 2026 fiscal year, pending customary closing conditions and regulatory approvals. Phreesia plans to finance the acquisition with cash from its balance sheet and a new bridge loan. The company anticipates the acquisition will add approximately $35 million in annualized revenue and $11 million in annualized Adjusted EBITDA. Advisors for the transaction include Goldman Sachs for Phreesia and Houlihan Lokey for AccessOne.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phreesia Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250904480505) on September 04, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10